Welgene Biotech Co.,Ltd. (TPEX: 6661)
Health Care · Life Sciences Tools & Services · TW
NT$17.15
+2.39% today · -15.3% 1Y
Welgene Biotech Co.,Ltd. (TPEX: 6661) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $12.55M and employs 80 people.
Over the last twelve months the share price has lost 15.3%, trading between 15.50 and 24.05.
Tweenvest scores Welgene Biotech Co.,Ltd. across four factors: quality 68/100, value 67/100, growth 24/100. Its strongest factor is quality.
6661 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $12.55M
- Revenue (TTM)
- $12.54M
- P/E
- —
- EPS
- -0.07
- Dividend yield
- —
- Beta (5Y)
- 0.20
- 52-week high
- NT$24.05
- 52-week low
- NT$15.50
- Avg volume (3M)
- —
- Shares outstanding
- 23.30M
- Employees
- 80
- Next earnings
- —
About Welgene Biotech Co.,Ltd.
Welgene Biotech Co.,Ltd. primarily focuses on delivering genetic analysis services. The company provides comprehensive support for scientific research, employing a range of advanced laboratory techniques such as genetic sequencing, microarray analysis, qPCR verification, nucleic acid extraction and quality control, LCM single cell experimentation, and intricate bioinformatics analysis. A key offering in their portfolio is Cytoscan, an array-based comparative genomic hybridization (CGH) solution. Beyond services, Welgene Biotech also supplies essential laboratory products, including various reagents, consumable items, and specialized instruments, alongside dedicated software solutions. Established in 2003, the company operates from its headquarters in Taipei City, Taiwan.
- ISIN
- TW0006661002
- Founded
- 2003
- Listed since
- Oct 23, 2017
- Exchange
- Taipei Exchange
- Currency
- TWD
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Thermo Fisher Scientific Inc.NYSE: TMO | $232.26B | $625.73 | -0.39% |
| Danaher CorporationNYSE: DHR | $151.82B | $212.94 | -1.40% |
| WuXi AppTec Co., Ltd.SHSE: 603259 | $71.35B | CN¥161.00 | +3.31% |
| Samsung Biologics Co.,Ltd.KOSE: A207940 | $51.75B | ₩1,551,000.00 | +0.19% |
| Lonza Group AGSWX: LONN | $51.65B | CHF592.80 | -0.17% |
| Agilent Technologies, Inc.NYSE: A | $43.71B | $153.73 | -0.67% |
| IQVIA Holdings Inc.NYSE: IQV | $42.70B | $260.83 | +0.54% |
| Waters CorporationNYSE: WAT | $40.72B | $411.89 | -0.62% |
Figures last refreshed Aug 18, 2026.